Gabriella d'ettorre
Gabriella d'ettorre
Verified email at
TitleCited byYear
A seven-year prospective study on spondylodiscitis: epidemiological and microbiological features
C D’agostino, L Scorzolini, AP Massetti, M Carnevalini, G d’Ettorre, ...
Infection 38 (2), 102-107, 2010
HIV-associated immune activation: from bench to bedside
G d'Ettorre, M Paiardini, G Ceccarelli, G Silvestri, V Vullo
AIDS research and human retroviruses 27 (4), 355-364, 2011
Probiotics reduce inflammation in antiretroviral treated, HIV-infected individuals: results of the “Probio-HIV” clinical trial
G d’Ettorre, G Ceccarelli, N Giustini, S Serafino, N Calantone, ...
PLoS One 10 (9), e0137200, 2015
Cross-presentation of caspase-cleaved apoptotic self antigens in HIV infection
PM Rawson, C Molette, M Videtta, L Altieri, D Franceschini, T Donato, ...
Nature medicine 13 (12), 1431, 2007
CD271 as a marker to identify mesenchymal stem cells from diverse sources before culture
M Álvarez-Viejo, Y Menéndez-Menéndez, J Otero-Hernández
World journal of stem cells 7 (2), 470, 2015
Vitamin D deficiency in HIV infection: an underestimated and undertreated epidemic
MR Pinzone, M Di Rosa, M Malaguarnera, G Madeddu, E Focà, ...
Eur Rev Med Pharmacol Sci 17 (9), 1218-32, 2013
Hospital-acquired infection surveillance in a neonatal intensive care unit
GB Orsi, G d'Ettorre, A Panero, F Chiarini, V Vullo, M Venditti
American journal of infection control 37 (3), 201-203, 2009
Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy
E Nicastri, L Sarmati, G d'Ettorre, L Palmisano, SG Parisi, I Uccella, ...
Journal of medical virology 69 (1), 1-6, 2003
Interleukin-15 in HIV infection: immunological and virological interactions in antiretroviral-naive and-treated patients
G d'Ettorre, G Forcina, M Lichtner, F Mengoni, C D'Agostino, AP Massetti, ...
Aids 16 (2), 181-188, 2002
HIV persistence in the gut mucosa of HIV-infected subjects undergoing antiretroviral therapy correlates with immune activation and increased levels of LPS
G d'Ettorre, M Paiardini, L Zaffiri, M Andreotti, G Ceccarelli, C Rizza, ...
Current HIV research 9 (3), 148-153, 2011
Ultrasensitive assessment of residual HIV viraemia in HAART‐treated patients with persistently undetectable plasma HIV‐RNA: A cross‐sectional evaluation
S Bonora, E Nicastri, A Calcagno, D Gonzalez de Requena, G D'Ettorre, ...
Journal of medical virology 81 (3), 400-405, 2009
Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells
G Matusali, HK Tchidjou, G Pontrelli, S Bernardi, G D'Ettorre, V Vullo, ...
The FASEB Journal 27 (6), 2440-2450, 2013
Interleukin-15 enhances neutrophil functional activity in patients with human immunodeficiency virus infection
CM Mastroianni, G d'Ettorre, G Forcina, M Lichtner, F Mengoni, ...
Blood 96 (5), 1979-1984, 2000
Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected …
S Di Giambenedetto, M Fabbiani, E Quiros Roldan, A Latini, G D’Ettorre, ...
Journal of Antimicrobial Chemotherapy 72 (4), 1163-1171, 2017
Rapid decline of fasting glucose in HCV diabetic patients treated with direct-acting antiviral agents
P Pavone, T Tieghi, G d'Ettorre, M Lichtner, R Marocco, I Mezzaroma, ...
Clinical Microbiology and Infection 22 (5), 462. e1-462. e3, 2016
Teaching tired T cells to fight HIV: time to test IL-15 for immunotherapy?
CM Mastroianni, G d'Ettorre, G Forcina, V Vullo
Trends in immunology 25 (3), 121-125, 2004
Multiclass HCV resistance to direct‐acting antiviral failure in real‐life patients advocates for tailored second‐line therapies
VC Di Maio, V Cento, I Lenci, M Aragri, P Rossi, S Barbaliscia, M Melis, ...
Liver International 37 (4), 514-528, 2017
Rhabdomyolysis after cerivastatin–gemfibrozil therapy in an HIV-infected patient with protease inhibitor-related hyperlipidemia
CM Mastroianni, G d'Ettorre, G Forcina, M Lichtner, A Corpolongo, ...
Aids 15 (6), 820-821, 2001
Kidney disease in HIV-infected patients
M Scarpino, MR Pinzone, M Di Rosa, G Madeddu, E Focà, F Martellotta, ...
Eur Rev Med Pharmacol Sci 17 (19), 2660-7, 2013
Drug-associated resistance mutations in plasma and peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected patients for whom highly active …
L Sarmati, E Nicastri, I Uccella, G d'Ettorre, SG Parisi, L Palmisano, ...
Journal of clinical microbiology 41 (4), 1760-1762, 2003
The system can't perform the operation now. Try again later.
Articles 1–20